KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Total Non-Current Liabilities: 2012-2025

Historic Total Non-Current Liabilities for Neogenomics (NEO) over the last 12 years, with Sep 2025 value amounting to $438.6 million.

  • Neogenomics' Total Non-Current Liabilities rose 0.49% to $438.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $438.6 million, marking a year-over-year increase of 0.49%. This contributed to the annual value of $434.5 million for FY2024, which is 32.47% down from last year.
  • Neogenomics' Total Non-Current Liabilities amounted to $438.6 million in Q3 2025, which was down 0.27% from $439.8 million recorded in Q2 2025.
  • Over the past 5 years, Neogenomics' Total Non-Current Liabilities peaked at $676.4 million during Q3 2021, and registered a low of $433.5 million during Q1 2025.
  • Moreover, its 3-year median value for Total Non-Current Liabilities was $439.8 million (2025), whereas its average is $530.4 million.
  • Per our database at Business Quant, Neogenomics' Total Non-Current Liabilities spiked by 265.36% in 2021 and then slumped by 32.47% in 2024.
  • Quarterly analysis of 5 years shows Neogenomics' Total Non-Current Liabilities stood at $674.3 million in 2021, then decreased by 3.29% to $652.1 million in 2022, then fell by 1.33% to $643.4 million in 2023, then slumped by 32.47% to $434.5 million in 2024, then grew by 0.49% to $438.6 million in 2025.
  • Its Total Non-Current Liabilities stands at $438.6 million for Q3 2025, versus $439.8 million for Q2 2025 and $433.5 million for Q1 2025.